Schrödinger will be attending, sponsoring, or presenting talks at the following events this spring:
Drug Design VI
London, UK
February 28–March 1
Schrödinger will be presenting at and is a sponsor of the Drug Design VI conference, being held February 28–March 1 in London. Dr. Jörg Weiser, Schrödinger Vice President of International Operations, will give a presentation on the application of quantum mechanics to docking, titled "Quantum Mechanics and Drug Design: Towards Higher Accuracy in Binding Mode and Affinity Predictions."
United Devices 3rd Annual Conference
Boston, MA
March 7–8
Dr. Peter S. Shenkin, Vice President at Schrödinger, will give a presentation titled Licensing and Other Grid "Hassles" at the United Devices 3rd Annual Conference, being held in Boston, MA, March 7–8. For further information, please visit the conference website.
233rd ACS National Meeting & Exposition
Chicago, IL
March 25–29
Schrödinger will exhibit (booth 311) and demonstrate its full suite of software solutions for drug discovery and design. Application case studies will be presented, and copies of Maestro, Schrödinger's all-purpose modeling program, will be freely distributed to all academic users.
The complete schedule of talks given by Schrödinger scientists is available on our website.
Spring 2007 Schrödinger User Symposium
New York City
April 15–17
Highlighting the very latest modeling results and technologies applied to drug discovery, The Symposium will take place at the Millennium Broadway Hotel in Times Square, located directly next to our New York office.
The Symposium includes two days filled with presentations by leading speakers from industry and academia, as well as opportunities to interact with Schrödinger scientists. Evening activities include a cocktail welcoming reception on 4/15, an evening reception including focused meetings with Schrödinger developers, and a closing reception on 4/17.
The registration deadline is March 30th, 2007. A list of speakers and presentations scheduled for the 2007 Symposium is available on our website.
Drug Discovery 2007
La Jolla, CA
May 14–16
Schrödinger will be presenting at and is a corporate sponsor of Drug Discovery 2007, being held in La Jolla, CA from May 14–16. Dr. Woody Sherman, Schrödinger's Director of Applications Science, will give two Technology Spotlight presentations:
Fragment-Based Drug Discovery
"Bridging
the Gap Between Ligand- and Structure-Based Approaches to Drug
Discovery with Pharmacophores Derived from Fragment Docking"
G-Protein Coupled Receptor Drug Discovery
"New GPCR Modeling Toolkit with a Focus on Structural Refinement of Homology Models"
In-Silico ADMET
London, UK
May 16–17
Schrödinger will be presenting at and is the corporate sponsor of In-Silico ADMET, being held in London from May 16–17. Dr. Richard Friesner, Professor of Chemistry at Columbia University and Schrödinger's Scientific Advisory Board Chairman, will give a presentation titled "Next Generation Docking & Homology Modelling Approaches Applied To ADMET Relevant Proteins."